Please login to the form below

Not currently logged in
Email:
Password:

Bioinformatics firm Eagle adds to senior team

Appoints Michael Reynolds and promotes Will Spooner and Glenn Proctor

Eagle has appointed Michael Reynolds as vice president of global sales as it prepares to launch a new bioinformatics software platform that will allow 'intelligent sharing' of genomic data later this year.

Reynolds joins the Cambridge, UK-based company from Pilgrim Software, where he was director of EMEA sales, and during a 20-year pharma and life sciences career his prior roles include stints at Smart Analyst, APC Pharma and Etrials.

Eagle Will SpoonerEagle Glenn Proctor 

Eagle has also promoted two members of its senior team, making Will Spooner (above left) chief scientific officer while Glenn Proctor (above right) becomes chief technical officer.

Spooner, who has previously served at the likes of the Wellcome Trust Sanger Institute and the European Bioinformatics Institute, will be responsible for ensuring that Eagle remains "at the forefront of bioinformatics knowledge", the company said.

Meanwhile, Proctor - who previously led the software development of Ensembl at the European Bioinformatics Institute - will be tasked with managing and improving Eagle's systems to best support customers.

Abel Ureta-Vidal, CEO of Eagle, said: “These appointments are critical to Eagle's ongoing success. Michael brings a wealth of sales and marketing experience, and will be pivotal in further building Eagle's business.

"With the appointments of Will and Glenn to their respective roles, we now have an expert management team which will ensure Eagle's customers are able to receive the maximum benefit from Eagle's comprehensive services.”

5th August 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics